Trials / Terminated
TerminatedNCT02430558
Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft
Second Line Treatment of Knee Osteochondral Lesion With Decellularized Treated Osteochondral Allograft. Phase IIa Trial
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- TBF Genie Tissulaire · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Patient with IKDC score \< 65, pretreated with mosaicplasty or ACI ( with matrix or not) within \> 18 months, with one or two osteochondral lesions are recruited to have treated osteochondral allografts in mosaicplasty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | OD-PHOENIX | Decellularized, freeze-dried, irradiated osteochondral allograft |
Timeline
- Start date
- 2016-04-05
- Primary completion
- 2021-06-15
- Completion
- 2021-06-15
- First posted
- 2015-04-30
- Last updated
- 2022-09-27
Source: ClinicalTrials.gov record NCT02430558. Inclusion in this directory is not an endorsement.